Literature DB >> 2760636

Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system.

T Mathiesen1, H von Holst, S Fredrikson, G Wirsén, B Hederstedt, E Norrby, V A Sundqvist, B Wahren.   

Abstract

Total IgG subclass levels, anti-viral, anti-myelin basic protein (anti-MBP), and anti-ganglioside 1 (anti-GM1) IgG subclass levels were measured in 6 patients with herpes simplex virus encephalitis (HSVE), 16 with borreliosis, 8 with other bacterial infections, 12 with multiple sclerosis (MS), 13 with subacute sclerosing panencephalitis (SSPE), 5 with glioblastoma and 12 controls. Total IgG1 levels were elevated in cerebrospinal fluid (CSF) from all patient groups (but not in the controls), IgG2 in bacterial infections, IgG3 in HSVE and borreliosis and IgG4 in some SSPE patients. The anti-viral (anti-measles, varicella zoster virus and rubella) IgG antibodies in MS were restricted to IgG1, anti-measles IgG to IgG1 and sometimes IgG4 in SSPE, anti-borrelia IgG to IgG1, IgG2 and IgG3. In contrast to anti-viral antibodies, anti-MBP and GM1 antibodies belonged to IgG1, IgG3 or IgG4 in MS. The nature of the immunological activation appears to be reflected in the subclass patterns elicited in the central nervous system. Different IgG subclass patterns in infectious diseases and MS suggest a difference between antigen-specific and non-specific B-cell activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760636     DOI: 10.1007/BF00314506

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  The use of human antigen-specific monoclonal antibodies in an enzyme-linked immunosorbent assay for the determination of anti-HBsAg antibody subclasses.

Authors:  M A Persson; L Hammarström; C I Smith; E A Stricker
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

3.  IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis.

Authors:  B Vandvik; J B Natvig; E Norrby
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

4.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

5.  Correlations between the concentrations of the four sub-classes of IgG and Gm Allotypes in normal human sera.

Authors:  A Morell; F Skvaril; A G Steinberg; E Van Loghem; W D Terry
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

6.  Detection of antibodies against myelin basic protein and increased levels of HIV-IgG antibodies and HIV antigen after solubilization of immune complexes in sera and CSF of HIV infected patients.

Authors:  T Mathiesen; A Sönnerborg; B Wahren
Journal:  Viral Immunol       Date:  1989       Impact factor: 2.257

7.  Sensitive analytic ELISAs for subclass herpes virus IgG.

Authors:  G Gilljam; V A Sundqvist; A Linde; P Pihlstedt; A E Eklund; B Wahren
Journal:  J Virol Methods       Date:  1985-03       Impact factor: 2.014

8.  Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies.

Authors:  W F Riesen; F Skvaril; D G Braun
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

9.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

10.  Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients.

Authors:  H Link; V Kostulas
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

View more
  7 in total

1.  Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.

Authors:  Jacqueline R Rivas; Sara J Ireland; Rati Chkheidze; William H Rounds; Joseph Lim; Jordan Johnson; Denise M O Ramirez; Ann J Ligocki; Ding Chen; Alyssa A Guzman; Mark Woodhall; Patrick C Wilson; Eric Meffre; Charles White; Benjamin M Greenberg; Patrick Waters; Lindsay G Cowell; Ann M Stowe; Nancy L Monson
Journal:  Acta Neuropathol       Date:  2016-10-11       Impact factor: 17.088

2.  Aberrant IgG subclass distribution to measles in healthy seropositive individuals, in patients with SSPE and in immunoglobulin-deficient patients.

Authors:  T Mathiesen; L Hammarström; E Fridell; A Linde; G Wirsen; C I Smith; E Norrby; B Wahren
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

3.  Recombinant antibodies generated from both clonal and less abundant plasma cell immunoglobulin G sequences in subacute sclerosing panencephalitis brain are directed against measles virus.

Authors:  Mark P Burgoon; Yupanqui A Caldas; Kathryne M Keays; Xiaoli Yu; Donald H Gilden; Gregory P Owens
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

Review 4.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

5.  IL-5 induces proliferation and activation of microglia via an unknown receptor.

Authors:  S M Liva; J de Vellis
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 6.  The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis.

Authors:  K C O'Connor; A Bar-Or; D A Hafler
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

7.  The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system.

Authors:  K Felgenhauer; H Reiber
Journal:  Clin Investig       Date:  1992-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.